Crossject
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster he… Read more
Crossject - Asset Resilience Ratio
Crossject (ALCJ) has an Asset Resilience Ratio of 1.31% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2021)
This chart shows how Crossject's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Crossject's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €181.00K | 0.65% |
| Short-term Investments | €181.00K | 0.65% |
| Total Liquid Assets | €362.00K | 1.31% |
Asset Resilience Insights
- Limited Liquidity: Crossject maintains only 1.31% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Crossject Industry Peers by Asset Resilience Ratio
Compare Crossject's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
Annual Asset Resilience Ratio for Crossject (2014–2021)
The table below shows the annual Asset Resilience Ratio data for Crossject.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.98% | €308.00K | €31.52 Million | +0.12pp |
| 2020-12-31 | 0.86% | €288.42K | €33.59 Million | +0.02pp |
| 2019-12-31 | 0.84% | €205.98K | €24.49 Million | +0.25pp |
| 2018-12-31 | 0.59% | €118.30K | €20.16 Million | -1.27pp |
| 2017-12-31 | 1.86% | €329.16K | €17.72 Million | +1.26pp |
| 2016-12-31 | 0.60% | €85.68K | €14.25 Million | -3.48pp |
| 2015-12-31 | 4.08% | €566.17K | €13.88 Million | +3.56pp |
| 2014-12-31 | 0.52% | €95.68K | €18.37 Million | -- |